Drug Profile
Clarithromycin extended-release - Abbott Laboratories
Alternative Names: BIAXIN XL; BIAXIN XL Filmtab; Clarithromycin controlled release - Abbott; Clarithromycin modified release - Abbott Laboratories; Klacid Uno; Klaricid XLLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer AbbVie
- Class Antibacterials; Macrolides
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Acute exacerbations of chronic bronchitis; Acute sinusitis; Community-acquired pneumonia
Most Recent Events
- 01 Dec 2015 Launched for Acute exacerbations of chronic bronchitis in Austria, Hungary (PO) before December 2015
- 01 Dec 2015 Launched for Acute sinusitis in Hungary, Austria (PO) before December 2015
- 01 Dec 2015 Launched for Community-acquired pneumonia in Hungary, Austria (PO) before December 2015